AlphAIAlphAI — Financial news for AI agents
yahoo.comAUG 252 min read$EL

Estee Lauder Stock Jumped On A Bigger Margin Promise

Estee Lauder Companies (EL) stock rose 18.4% after reporting fiscal 2026 results and raising its fiscal 2027 profit margin outlook. Revenue was $3.6B, up 6% YoY, beating estimates. Management guided fiscal 2027 organic growth of 3% to 5%. Operating margin improved to 11.2%, with expectations of 12.7% to 13.5% for fiscal 2027. Cash from operations is expected to decrease to $1.3B to $1.4B due to restructuring costs.

Original reporting
yahoo.com
Published Aug 25, 2026, 11:00 PM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Aug 25, 2026, 11:27 PM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
About AlphAI AI DeskScoring methodologyReport an issue
Estee Lauder Stock Jumped On A Bigger Margin Promise — source image
Source · yahoo.com
Decision brief

The 30-second read

$ELBullishMed
01

Why it matters

The guidance lift underpins the 18% price surge and signals a turnaround, but lower cash‑flow guidance tempers optimism.

02

Market read

Earnings beat and margin upgrade provide a clear catalyst for traders; peers show weaker moves.

03

What to watch

Higher restructuring payments and lower cash flow guidance could constrain near‑term liquidity.

Relevance 8/10Novelty 8/10Timing: post‑earnings release today

Background

Estee Lauder posted FY2026 revenue of $3.6 bn (+6% YoY) and operating margin of 11.2%, then raised FY2027 margin guidance to 12.7‑13.5%.

Company-level read

Ticker impact

$ELBullishHigh confidence
Context

Estee Lauder reported FY2026 results and raised FY2027 profit margin guidance, driving an 18.4% stock jump.

Expected impact

Potential further upside if guidance holds; watch for earnings beat confirmation.

Evidence & confidence

Guidance lift is material, backed by operating margin improvement and cost cuts.

Market effects

Sector

Beauty sector may see mixed reactions; peers like Coty lag behind, e.l.f. gains modestly.

Regional

Limited to North American consumer discretionary markets.

Global

Minor global impact; primarily U.S. equity investors.

Counterpoint

What could challenge this read

Margin guidance may be optimistic given modest organic sales growth; watch for cash flow pressure in FY2027.

Key entities

  • Company
    Estee Lauder Companies

    Global beauty products manufacturer (ticker EL).

Read at source← All news

Related articles

SEP 15
$ELMed

Estee Lauder outlook revised to stable by S&P on deleveraging

S&P Global Ratings revised Estee Lauder's outlook to stable from negative, citing improved operating results and credit metrics. The agency expects adjusted leverage to fall to 1.9x by fiscal 2027, with mid-single-digit revenue growth and expanded EBITDA margins. Cash flows are projected to decline due to restructuring and investments, but the company plans to use cash balances for debt repayment.

investing.com2 min
AUG 28
$ELHighAI 8/10

Estée Lauder (EL)’s China Bet Just Paid Off. Its Makeup Business Still Hasn’t Caught Up

Estée Lauder (EL) reported Q4 net sales of $3.63B, up 6.3%, driven by luxury fragrance and skincare. It forecasted fiscal 2027 adjusted EPS of $3.10-$3.35, above estimates, sending shares up 11% premarket. However, makeup sales were flat, and hair care dropped 1%. The company also reported a $38M tariff-refund benefit and a net loss of $116M, down from $546M a year earlier.

yahoo.com2 min
AUG 28
$ELMedAI 8/10

Estee Lauder vs Nike: One Turnaround Just Proved Itself, the Other Keeps Slipping

Estee Lauder (EL) reported four consecutive earnings beats, raising its fiscal 2027 EPS guidance to $3.10-$3.35. Nike (NKE) guided revenue down, with Greater China down 12% and Converse down 32%. EL's stock rose 10.46% post-earnings, while NKE's turnaround timeline extends. EL's forward P/E is near 32, with a 1.3% yield. NKE offers a 4.3% yield but faces declining revenue.

aol.com3 min
AUG 27
$MRNAHighAI 8/10

3 Stocks Soared, 3 Stocks Slumped

Moderna (MRNA) surged 176.97% to $174.38 after reporting positive trial results for a cancer therapy with Merck (MRK). Estee Lauder (EL) rose 16% to $98.01 with revenue up 6.5% Y/Y. MicroStrategy (MSTR) gained 12.68% as Bitcoin prices rose. Nebius (NBIS) fell 10% after a $4.5B convertible note offering. Seagate (STX) dropped 8% to $832.56.

baystreet.ca2 min
AUG 27
$ELHighAI 8/10

Estée Lauder’s (EL) Turnaround Story Just Got Real Numbers Behind It

Estée Lauder (EL) reported fiscal 2026 Q4 and full-year earnings, showing organic net sales up 3%, adjusted operating margin at 11.2%, and adjusted diluted EPS at $2.51. Fragrance and Skin Care led growth, with Jo Malone and TOM FORD joining the billion-dollar brand club. The company guided fiscal 2027 organic sales growth of 3% to 5% and adjusted operating margin of 12.7% to 13.5%. Challenges include Middle East conflict impacts and Hair Care declines. Hedge fund ownership held steady at 47 fun

insidermonkey.com3 min
AUG 26
$ELHighAI 9/10

Estée Lauder (EL) Q4 2026 Earnings Call Transcript

Estée Lauder (EL) reported 3% organic net sales growth for fiscal 2026, with adjusted EPS of $2.51, up 66%. Key drivers included 10% fragrance sales growth and 9% growth in Mainland China. Guidance for fiscal 2027 includes 3-5% organic sales growth and adjusted EPS of $3.10-$3.35. Management highlighted margin expansion and strategic initiatives, including headcount reductions and digital investments.

aol.com3 min